ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,019	957.8	726.44	517.24	484.15	441.76
Revenue Growth (YoY)	14.41%	31.85%	40.45%	6.83%	9.60%	30.28%
Cost of Revenue	405.34	385.09	393.26	371.74	258.56	286.88
Gross Profit	613.55	572.71	333.18	145.49	225.59	154.88
Selling, General & Admin	523.25	488.43	406.56	369.09	396.03	388.66
Operating Expenses	523.25	488.43	406.56	369.09	396.03	388.66
Operating Income	90.3	84.28	-73.38	-223.6	-170.44	-233.79
Interest & Investment Income	28.74	25.46	17.23	6.61	0.59	6.61
Other Non Operating Income (Expenses)	2.33	1.82	-	-	-	-
EBT Excluding Unusual Items	121.37	111.56	-56.15	-216.99	-169.85	-227.18
Merger & Restructuring Charges	-	-	-	-	-	-52.8
Gain (Loss) on Sale of Investments	-	-	5.11	3.54	2.33	-1
Gain (Loss) on Sale of Assets	146.52	146.52	-	-	-	-
Pretax Income	267.88	258.08	-51.04	-213.44	-167.52	-280.97
Income Tax Expense	45.72	31.62	10.25	2.53	0.35	0.61
Net Income	222.16	226.45	-61.29	-215.98	-167.87	-281.58
Net Income to Common	222.16	226.45	-61.29	-215.98	-167.87	-281.58
Shares Outstanding (Basic)	167	166	164	162	160	157
Shares Outstanding (Diluted)	167	166	164	162	160	157
Shares Change (YoY)	1.10%	1.55%	1.32%	0.74%	2.01%	6.88%
EPS (Basic)	1.33	1.37	-0.37	-1.34	-1.05	-1.79
EPS (Diluted)	1.33	1.36	-0.37	-1.34	-1.05	-1.79
Free Cash Flow	187.09	157.2	16.65	-114.04	-126.78	-143.75
Free Cash Flow Per Share	1.12	0.94	0.10	-0.70	-0.79	-0.91
Gross Margin	60.22%	59.79%	45.87%	28.13%	46.59%	35.06%
Operating Margin	8.86%	8.80%	-10.10%	-43.23%	-35.20%	-52.92%
Profit Margin	21.80%	23.64%	-8.44%	-41.76%	-34.67%	-63.74%
Free Cash Flow Margin	18.36%	16.41%	2.29%	-22.05%	-26.19%	-32.54%
EBITDA	103.97	100.16	-67.83	-221.57	-167.1	-230.85
EBITDA Margin	10.20%	10.46%	-9.34%	-42.84%	-34.51%	-52.26%
D&A For EBITDA	13.67	15.88	5.55	2.03	3.34	2.93
EBIT	90.3	84.28	-73.38	-223.6	-170.44	-233.79
EBIT Margin	8.86%	8.80%	-10.10%	-43.23%	-35.20%	-52.92%
Effective Tax Rate	17.07%	12.25%	-	-	-	-
Revenue as Reported	1,019	957.8	726.44	517.24	484.15	441.76
Advertising Expenses	-	21.1	9.4	5.5	41.8	51.1

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q